Loading...
Closing of public offering of Argos Therapeutics
24-Feb-2014
- USA
Advertisement
Forbion Capital Partners announces that its portfolio company Argos Therapeutics has closed its initial public offering.
The initial public offering price was $8.00 per ordinary share. Argos' ordinary shares have listed on the NASDAQ Global Market and began trading under the symbol "ARGS" on 7 February 2014.